Wiley Perry Ballard III MD

Piedmont Cancer Institute - Atlanta

Education and Training

Specialty and Certification

Medical Oncology / Board Certified

Clinical Trial Cancer Types

Breast Cancer, Lung Cancer, Prostate Cancer

Affiliations

Georgia CORE Piedmont Hospital
Piedmont Fayette Hospital Piedmont Newnan Hospital

Active Clinical Trial Sites in Georgia

Piedmont Cancer Institute - Atlanta

1800 Howell Mill Road
Suite 800
Atlanta, GA 30318
404-350-9853 (p)
404-350-8407 (f)
www.piedmontcancerinstitute.com

driving directions

Clinical Trials
A Randomized, Open-Label, Multicenter Study of Eribulin Mesylate in Combination with PEGylated Recombinant Human Hyaluronidase (PEGPH20) versus Eribulin Mesylate Alone in Subjects with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer
Cancer Type: Breast Cancer

A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients with Clinical/Radiologic Complete Response after Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment without Surgery
Cancer Type: Breast Cancer

Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion
Cancer Type: Lung Cancer

A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer
Cancer Type: Prostate Cancer

A Phase 1 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI9447 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
Cancer Type: Unknown Primary


Active Clinical Trial Site Locations: